Sign In
Buy DHR
$178.08
+1.97 (+1.12%)
At Close: Jun 03, 2026
Danaher (DHR) Benefits From Business Strength Amid Risks
12:30pm, Friday, 16'th Aug 2024
Danaher (DHR) benefits from strength in the clinical diagnostics business, Abcam buyout and pro-investor policies. However, softness in its Instrument unit is concerning.
Betting Big: 3 Dividend Stocks My Family And I Are Buying Aggressively
07:30am, Tuesday, 30'th Jul 2024
Market corrections happen under almost every president, and stock performance is not tied to political parties. Currently, inflation remains the key driver of market movements. Focus on undervalued op
HTHIY or DHR: Which Is the Better Value Stock Right Now?
12:40pm, Friday, 26'th Jul 2024
Investors looking for stocks in the Diversified Operations sector might want to consider either Hitachi Ltd. (HTHIY) or Danaher (DHR).
Final Trades: Freeport-McMoran, Pfizer, Danaher and United Rentals
01:45pm, Thursday, 25'th Jul 2024
The Investment Committee give you their top stocks to watch for the second half.
Beckman Coulter's DxI 9000 Immunoassay Analyzer Honored at Premier, Inc.'s Annual Supplier Innovation Celebration
09:00am, Thursday, 25'th Jul 2024
BREA, Calif. , July 25, 2024 /PRNewswire/ -- Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the DxI 9000 Immunoassay Analyzer* was honored during Premier, Inc.'s ann
Danaher (DHR) Q2 Earnings Beat, Biotechnology Sales Dip Y/Y
01:26pm, Tuesday, 23'rd Jul 2024
Danaher's (DHR) second-quarter earnings and revenues surpass estimates. However, the company's performance reflects a decrease in core sales in the Biotechnology segment.
Danaher Stock Soars on Q2 Earnings Beat
12:21pm, Tuesday, 23'rd Jul 2024
Danaher Corp. (DHR) beat analysts' expectations on the top and bottom lines with its second-quarter results, sending shares higher in intraday trading Tuesday.
Here's Why Danaher Stock Surged Today
11:50am, Tuesday, 23'rd Jul 2024
The pandemic has created a lot of noise around Danaher's revenue growth, but the dust looks set to settle in 2024. Core revenue and margins were better than expected in the second quarter.
Here's What Key Metrics Tell Us About Danaher (DHR) Q2 Earnings
10:36am, Tuesday, 23'rd Jul 2024
The headline numbers for Danaher (DHR) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates
Danaher Corporation (DHR) Q2 2024 Earnings Call Transcript
10:35am, Tuesday, 23'rd Jul 2024
Danaher Corporation (NYSE:DHR ) Q2 2024 Earnings Conference Call July 23, 2024 8:00 AM ET Company Participants John Bedford - VP of IR Rainer M. Blair - President & CEO Matt McGrew - EVP & CFO Confere
Danaher Stock Surges. More Than Earnings Are Driving It Higher.
08:39am, Tuesday, 23'rd Jul 2024
Danaher reports second-quarter adjusted earnings of $1.72 a share on revenue of $5.74 billion.
Danaher (DHR) Q2 Earnings and Revenues Beat Estimates
08:10am, Tuesday, 23'rd Jul 2024
Danaher (DHR) came out with quarterly earnings of $1.72 per share, beating the Zacks Consensus Estimate of $1.57 per share. This compares to earnings of $2.05 per share a year ago.
Danaher beats Q2 profit estimates on strength in medical testing business
07:32am, Tuesday, 23'rd Jul 2024
Danaher beat Wall Street estimates for second-quarter profit and revenue on Tuesday, driven by strong demand for its genetic testing services, sending shares of the life sciences firm up nearly 8% in
Danaher Reports Second Quarter 2024 Results
06:00am, Tuesday, 23'rd Jul 2024
WASHINGTON , July 23, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the quarter ended June 28, 2024. All results in this release reflect only conti
Will Danaher (DHR) Beat Estimates Again in Its Next Earnings Report?
01:16pm, Friday, 19'th Jul 2024
Danaher (DHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
